Insider Trading: Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

135.45USD
17 Apr 2014
Price Change (% chg)

$-0.77 (-0.57%)
Prev Close
$136.22
Open
$136.93
Day's High
$138.33
Day's Low
$133.66
Volume
1,123,011
Avg. Vol
2,256,679
52-wk High
$183.30
52-wk Low
$54.84

Search Stocks
NACLERIO NICHOLAS J Options Exercised: 548
Trade Date: Monday, 28 Jan 2013 Price: 0.00
Title: Officer Shares Held: 25,976
Type Traded: Direct Net Change in Shares This Filing: 3,910

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 515
Total Shares Held: 152,356,070
3 Mo. Net Change: 5,211,806
# New Positions: 19
# Closed Positions: 5
# Increased Positions: 36
# Reduced Positions: 32
# Net Buyers: 4

Officers & Directors

Name Age Since Current Position

William Rastetter

65 2005 Chairman of the Board

Francis deSouza

42 2014 President, Director

Jay Flatley

61 2013 Chief Executive Officer, Director

Marc Stapley

43 2012 Chief Financial Officer, Senior Vice President

David Walt

60 1998 Chairman - Scientific Advisory Board, Independent Director

Mostafa Ronaghi

44 2008 Chief Technology Officer, Senior Vice President

Charles Dadswell

2013 Senior Vice President, General Counsel, Secretary

Gregory Heath

55 2008 Senior Vice President, General Manager - Diagnostics

Christian Henry

45 2012 Senior Vice President, General Manager - Genetic Analysis

Mark Lewis

60 2012 Senior Vice President, General Manager - Molecular Biology and PCR

Matthew Posard

46 2012 Senior Vice President, General Manager - Translational and Consumer Genomics

Paul Bianchi

51 2012 Senior Vice President - Human Resources

Richard Klausner

2013 Senior Vice President, Chief Medical Officer

Nicholas Naclerio

40 2011 Senior Vice President - Corporate and Venture Development

Tristan Orpin

47 2010 Chief Commercial Officer, Senior Vice President

Arthur Bowman

66 2007 Independent Director

Daniel Bradbury

52 2004 Independent Director

Karin Eastham

63 2004 Independent Director

Robert Epstein

57 2012 Independent Director

Gerald Moller

69 2010 Independent Director

Roy Whitfield

59 2007 Independent Director

Rebecca Chambers

Senior Director - Investor Relations
Search Stocks